Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer
作者： Federico Cappuzzo , Fred R. Hirsch , Elisa Rossi , Stefania Bartolini , Giovanni L. Ceresoli
DOI: 10.1093/JNCI/DJI112
关键词:
摘要: Background: Gefitinib is a selective inhibitor of the epidermal growth factor (EGFR) tyrosine kinase, which is overexpressed in many cancers, including non–small-cell lung cancer (…
oup.com
core.ac.uk
oxfordjournals.org
elsevier.com
paperity.org参考文章(44)
R.H. Don, P. T. Cox, B.J. Wainwright, K. Baker, J. S. Mattick, 'Touchdown' PCR to circumvent spurious priming during gene amplification Nucleic Acids Research. ,vol. 19, pp. 4008- 4008 ,(1991) , 10.1093/NAR/19.14.4008
Renee Bailey, Mark Kris, Michael Wolf, Andrea Kay, Steven Averbuch, Jon Askaa, Mette Janas, Karsten Schmidt, Masahiro Fukuoka, O-242 Gefitinib (‘Iressa’, ZD1839) monotherapy for pretreated advanced non-small-cell lung cancer in IDEAL 1 and 2: tumor response is not clinically relevantly predictable from tumor EGFR membrane staining alone Lung Cancer. ,vol. 41, ,(2003) , 10.1016/S0169-5002(03)91900-3
Fred R. Hirsch, Giorgio V. Scagliotti, Corey J. Langer, Marileila Varella-Garcia, Wilbur A. Franklin, Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies. Lung Cancer. ,vol. 41, pp. 29- 42 ,(2003) , 10.1016/S0169-5002(03)00137-5
C ARTEAGA, Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia. Seminars in Oncology. ,vol. 29, pp. 3- 9 ,(2002) , 10.1016/S0093-7754(02)70085-7
C. David James, Greg Eley, Xiao Yang Wang, Lori Frederick, Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Research. ,vol. 60, pp. 1383- 1387 ,(2000)
Vincent A. Miller, Mark G. Kris, Neelam Shah, Jyoti Patel, Christopher Azzoli, Jorge Gomez, Lee M. Krug, William Pao, Naiyer Rizvi, Barbara Pizzo, Leslie Tyson, Ennapadam Venkatraman, Leah Ben-Porat, Natalie Memoli, Maureen Zakowski, Valerie Rusch, Robert T. Heelan, Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 22, pp. 1103- 1109 ,(2004) , 10.1200/JCO.2004.08.158
Mark G. Kris, Ronald B. Natale, Roy S. Herbst, Thomas J. Lynch, Jr, Diane Prager, Chandra P. Belani, Joan H. Schiller, Karen Kelly, Harris Spiridonidis, Alan Sandler, Kathy S. Albain, David Cella, Michael K. Wolf, Steven D. Averbuch, Judith J. Ochs, Andrea C. Kay, Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients with Non-Small Cell Lung Cancer: A Randomized Trial JAMA. ,vol. 290, pp. 2149- 2158 ,(2003) , 10.1001/JAMA.290.16.2149
D Maxwell Parkin, Global cancer statistics in the year 2000 The Lancet Oncology. ,vol. 2, pp. 533- 543 ,(2001) , 10.1016/S1470-2045(01)00486-7
Fred R. Hirsch, Marileila Varella-Garcia, Paul A. Bunn, Michael V. Di Maria, Robert Veve, Roy M. Bremnes, Anna E. Barón, Chan Zeng, Wilbur A. Franklin, Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. Journal of Clinical Oncology. ,vol. 21, pp. 3798- 3807 ,(2003) , 10.1200/JCO.2003.11.069
W. Pao, V. Miller, M. Zakowski, J. Doherty, K. Politi, I. Sarkaria, B. Singh, R. Heelan, V. Rusch, L. Fulton, E. Mardis, D. Kupfer, R. Wilson, M. Kris, H. Varmus, EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 13306- 13311 ,(2004) , 10.1073/PNAS.0405220101